Salud financiera de hoja de balance de Test Research

Salud financiera controles de criterios 6/6

Test Research tiene un patrimonio de accionistas total de NT$7.2B y una deuda total de NT$0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son NT$8.9B y NT$1.7B respectivamente. El BAIT de Test Research es de NT$1.2B, por lo que su ratio de cobertura de intereses es de -104.8. Tiene efectivo e inversiones a corto plazo que ascienden a NT$1.4B.

Información clave

Ratio deuda-patrimonio

NT$0

Deuda

Ratio de cobertura de intereses	-104.8x
Efectivo	NT$1.35b
Patrimonio	NT$7.19b
Total pasivo	NT$1.72b
Activos totales	NT$8.91b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Test Research (TPE:3030) Has Compensated Shareholders With A Respectable 70% Return On Their Investment

Jan 24

Is Test Research, Inc.'s (TPE:3030) Latest Stock Performance Being Led By Its Strong Fundamentals?

Jan 05

Is Test Research, Inc. (TPE:3030) A Good Dividend Stock?

Dec 18

Here's Why I Think Test Research (TPE:3030) Is An Interesting Stock

Nov 30

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$5.0B) de 3030 superan a sus pasivos a corto plazo (NT$1.4B).

Pasivo a largo plazo: Los activos a corto plazo de 3030 (NT$5.0B) superan a sus pasivos a largo plazo (NT$272.7M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 3030 está libre de deudas.

Reducción de la deuda: 3030 no ha tenido ninguna deuda en los últimos 5 años.

Cobertura de la deuda: 3030 no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.

Cobertura de intereses: 3030 no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.

Salud financiera de hoja de balance de Test Research

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Test Research, Inc. to Report Q1, 2024 Results on May 08, 2024

Test Research, Inc. to Report Q1, 2024 Results on May 08, 2024

Test Research, Inc.'s (TWSE:3030) 25% Share Price Surge Not Quite Adding Up

Full year 2023 earnings released: EPS: NT$4.24 (vs NT$8.13 in FY 2022)

Test Research, Inc., Annual General Meeting, May 29, 2024

Now 20% overvalued after recent price rise

Test Research, Inc. Appoints Dino Tsai as Chief Information Security Officer

Third quarter 2023 earnings released: EPS: NT$1.04 (vs NT$2.06 in 3Q 2022)

Second quarter 2023 earnings released: EPS: NT$0.87 (vs NT$2.22 in 2Q 2022)

Upcoming dividend of NT$4.50 per share at 7.0% yield

Full year 2022 earnings released: EPS: NT$8.13 (vs NT$5.02 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: NT$2.06 (vs NT$1.22 in 3Q 2021)

Second quarter 2022 earnings released: EPS: NT$2.22 (vs NT$1.47 in 2Q 2021)

Upcoming dividend of NT$3.30 per share

First quarter 2022 earnings released: EPS: NT$2.50 (vs NT$1.25 in 1Q 2021)

Less than half of directors are independent

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Test Research, Inc., Annual General Meeting, May 25, 2022

Third quarter 2021 earnings released: EPS NT$1.22 (vs NT$1.32 in 3Q 2020)

Second quarter 2021 earnings released: EPS NT$1.47 (vs NT$1.58 in 2Q 2020)

Upcoming dividend of NT$3.30 per share

First quarter 2021 earnings released: EPS NT$1.25 (vs NT$1.14 in 1Q 2020)

Is Test Research, Inc. (TPE:3030) A Smart Choice For Dividend Investors?

With EPS Growth And More, Test Research (TPE:3030) Is Interesting

Full year 2020 earnings released: EPS NT$4.63 (vs NT$3.97 in FY 2019)

Test Research, Inc., Annual General Meeting, May 26, 2021

Test Research, Inc. Announces Change to the Research and Development Officer, Effective March 1, 2021

New 90-day high: NT$59.10

Should You Invest In Test Research (TPE:3030)?

Test Research, Inc. Announces Retirement of KuangPu Wen as Research and Development Officer

Test Research (TPE:3030) Has Compensated Shareholders With A Respectable 70% Return On Their Investment

Is Test Research, Inc.'s (TPE:3030) Latest Stock Performance Being Led By Its Strong Fundamentals?

Is Test Research, Inc. (TPE:3030) A Good Dividend Stock?

Here's Why I Think Test Research (TPE:3030) Is An Interesting Stock

Third quarter 2020 earnings released: EPS NT$1.32

New 90-day high - NT$59.60

First half earnings released

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera